Funder: National Institutes of Health
Due Dates: March 5, 2025 | July 5, 2025 | November 5, 2025 | March 5, 2026 | July 5, 2026 | November 5, 2026 | March 5, 2027 | July 5, 2027 | November 5, 2027
Funding Amounts: No budget cap; budgets must reflect actual needs. Maximum project period: 5 years.
Summary: Limited competition for renewals of existing NINDS-supported clinical trial U01 cooperative agreements needing additional time/resources to complete the trial.
Key Information: Only renewals of specific NINDS U01 clinical trial awards are eligible; new aims are not allowed.